MINORYX THERAPEUTICS

minoryx-firma

Biotech company focused on the development of new therapies

Advanced clinical stage biotechnology focused on the development of new therapies for orphan and severe genetic diseases of the central nervous system with high unmet medical need such as AML or cALD.

CEO: Marc Martinell.

INVESTED COMPANY
2022

Details

Minoryx Therapeutics
Av. Ernest Lluch 32 – TCM3

08302 Mataró (Barcelona), España

News